BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 36065726)

  • 1. Country data on AMR in India in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Poojary A; Shenoy B; Nijhara P; Dalal K; Manenzhe R
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i10-i17. PubMed ID: 36065726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Country data on AMR in Russia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Kozlov R; Sidorenko S; Kamble P; Lezhnina M; Galushkin A; Kundu S
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i61-i69. PubMed ID: 36065732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome.
    Torumkuney D; Kundu S; Vu GV; Nguyen HA; Pham HV; Kamble P; Truong Ha Lan N; Keles N
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i26-i34. PubMed ID: 36065731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Country data on AMR in Mexico in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; de la Torre C; Langfeld K; Lopez-Turrent NP; Ossaille Beltrame C
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i43-i50. PubMed ID: 36065728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Jamil B; Nizamuddin S; van Hasselt J; Pirzada U; Manenzhe R
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i18-i25. PubMed ID: 36065729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Nijhara P; Beltrame CO; Baisch EQ; Ferreira RM
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i35-i42. PubMed ID: 36065730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Country data on AMR in Türkiye in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Aktas Z; Unal S; van Hasselt J; Seyhun Y; Keles N
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i51-i60. PubMed ID: 36065733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Country data on AMR in Saudi Arabia in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Dolgum S; van Hasselt J; Abdullah W; Keles N
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i70-i76. PubMed ID: 36065727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Country data on AMR in Kuwait in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.
    Torumkuney D; Behbehani N; van Hasselt J; Hamouda M; Keles N
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i77-i83. PubMed ID: 36065725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022.
    Cantón R; Akova M; Langfeld K; Torumkuney D
    J Antimicrob Chemother; 2022 Sep; 77(Suppl_1):i2-i9. PubMed ID: 36065724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.
    Zafar A; Hasan R; Nizamuddin S; Mahmood N; Mukhtar S; Ali F; Morrissey I; Barker K; Torumkuney D
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i103-9. PubMed ID: 27048578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion.
    Bizri AR; El-Fattah AA; Bazaraa HM; Al Ramahi JW; Matar M; Ali RAN; El Masry R; Moussa J; Abbas AJA; Aziz MA
    PLoS One; 2023; 18(7):e0288550. PubMed ID: 37498951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections.
    Felmingham D; Feldman C; Hryniewicz W; Klugman K; Kohno S; Low DE; Mendes C; Rodloff AC
    Clin Microbiol Infect; 2002; 8 Suppl 2():12-42. PubMed ID: 12427206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for surveillance of antimicrobial-resistant bacteria causing community-acquired urinary tract infections in low-income countries.
    Majigo MV; Mshana S; Komba E; Moremi N; Matee M
    PLoS One; 2024; 19(5):e0304388. PubMed ID: 38820392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical assessment of published guidelines and other decision-support systems for the antibiotic treatment of community-acquired respiratory tract infections.
    Finch RG; Low DE
    Clin Microbiol Infect; 2002; 8 Suppl 2():69-91. PubMed ID: 12427208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An audit and feedback intervention study increased adherence to antibiotic prescribing guidelines at a Norwegian hospital.
    Høgli JU; Garcia BH; Skjold F; Skogen V; Småbrekke L
    BMC Infect Dis; 2016 Feb; 16():96. PubMed ID: 26920549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey.
    Torumkuney D; Gur D; Soyletir G; Gurler N; Aktas Z; Sener B; Tunger A; Bayramoglu G; Koksal I; Yalcin AN; Tanriver Y; Morrissey I; Barker K
    J Antimicrob Chemother; 2016 May; 71 Suppl 1(Suppl 1):i85-91. PubMed ID: 27048585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections.
    Ehrhardt AF; Russo R
    Am J Med; 2001 Dec; 111 Suppl 9A():30S-35S discussion 36S-38S. PubMed ID: 11755441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.